10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference
Rhea-AI Summary
10x Genomics (Nasdaq: TXG), a pioneer in single cell and spatial biology, has announced its upcoming participation in the BofA Securities 2025 Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Tuesday, May 13, at 11:20 a.m. Pacific Time.
Investors and interested parties can access the event through a live webcast available on the company's investor relations website at investors.10xgenomics.com. For those unable to attend the live session, the webcast recording will remain accessible for a minimum of 30 days following the event.
Positive
- Management's participation in a major healthcare conference indicates continued market visibility and investor relations efforts
Negative
- None.
News Market Reaction – TXG
In the trading session that priced this news, TXG declined 2.06%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-participate-in-the-bofa-securities-2025-healthcare-conference-302441921.html
SOURCE 10x Genomics, Inc.